BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32373908)

  • 1. Evidence that levels of nine essential metals in post-mortem human-Alzheimer's-brain and ex vivo rat-brain tissues are unaffected by differences in post-mortem delay, age, disease staging, and brain bank location.
    Scholefield M; Church SJ; Xu J; Kassab S; Gardiner NJ; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Metallomics; 2020 Jun; 12(6):952-962. PubMed ID: 32373908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Alterations of Post-Mortem Delay and Other Tissue-Collection Variables on Metabolite Levels in Human and Rat Brain.
    Scholefield M; Church SJ; Xu J; Robinson AC; Gardiner NJ; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Metabolites; 2020 Oct; 10(11):. PubMed ID: 33138273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia.
    Xu J; Church SJ; Patassini S; Begley P; Waldvogel HJ; Curtis MA; Faull RLM; Unwin RD; Cooper GJS
    Metallomics; 2017 Aug; 9(8):1106-1119. PubMed ID: 28654115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy.
    Solovyev N; El-Khatib AH; Costas-Rodríguez M; Schwab K; Griffin E; Raab A; Platt B; Theuring F; Vogl J; Vanhaecke F
    J Biol Chem; 2021; 296():100292. PubMed ID: 33453282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
    Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
    Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology.
    Malakooti N; Roberts B; Pritchard MA; Volitakis I; Kim RC; Lott IT; McLean CA; Finkelstein DI; Adlard PA
    Metallomics; 2020 Jan; 12(1):114-132. PubMed ID: 31764918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.
    Genoud S; Roberts BR; Gunn AP; Halliday GM; Lewis SJG; Ball HJ; Hare DJ; Double KL
    Metallomics; 2017 Oct; 9(10):1447-1455. PubMed ID: 28944802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia.
    Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Front Aging Neurosci; 2021; 13():641222. PubMed ID: 33746735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies.
    Graham SF; Nasaruddin MB; Carey M; Holscher C; McGuinness B; Kehoe PG; Love S; Passmore P; Elliott CT; Meharg AA; Green BD
    J Alzheimers Dis; 2014; 42(4):1407-13. PubMed ID: 25024342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy.
    Rao SS; Lago L; Gonzalez de Vega R; Bray L; Hare DJ; Clases D; Doble PA; Adlard PA
    Metallomics; 2020 Feb; 12(2):301-313. PubMed ID: 31904058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.
    Szabo ST; Harry GJ; Hayden KM; Szabo DT; Birnbaum L
    Toxicol Sci; 2016 Apr; 150(2):292-300. PubMed ID: 26721301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer's disease: metabolic basis for dementia.
    Xu J; Begley P; Church SJ; Patassini S; McHarg S; Kureishy N; Hollywood KA; Waldvogel HJ; Liu H; Zhang S; Lin W; Herholz K; Turner C; Synek BJ; Curtis MA; Rivers-Auty J; Lawrence CB; Kellett KA; Hooper NM; Vardy ER; Wu D; Unwin RD; Faull RL; Dowsey AW; Cooper GJ
    Sci Rep; 2016 Jun; 6():27524. PubMed ID: 27276998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.
    Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ
    Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry.
    Panayi AE; Spyrou NM; Iversen BS; White MA; Part P
    J Neurol Sci; 2002 Mar; 195(1):1-10. PubMed ID: 11867068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease.
    Schrag M; Crofton A; Zabel M; Jiffry A; Kirsch D; Dickson A; Mao XW; Vinters HV; Domaille DW; Chang CJ; Kirsch W
    J Alzheimers Dis; 2011; 24(1):137-49. PubMed ID: 21187585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metals and the liver in Alzheimer's disease. An investigation of hepatic zinc, copper, cadmium, and metallothionein.
    Lui E; Fisman M; Wong C; Diaz F
    J Am Geriatr Soc; 1990 Jun; 38(6):633-9. PubMed ID: 2358624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metal theory of Alzheimer's disease.
    Bush AI
    J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.
    Schrag M; Mueller C; Oyoyo U; Smith MA; Kirsch WM
    Prog Neurobiol; 2011 Aug; 94(3):296-306. PubMed ID: 21600264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative MRI and laser ablation-inductively coupled plasma-mass spectrometry imaging of iron in the frontal cortex of healthy controls and Alzheimer's disease patients.
    Bulk M; Abdelmoula WM; Geut H; Wiarda W; Ronen I; Dijkstra J; van der Weerd L
    Neuroimage; 2020 Jul; 215():116808. PubMed ID: 32289451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.